Search research articles
Contact Us
Filters
Showing results (111-120 of 278) with videos related to
Page
of 28
Sort By:
Pharmacotherapy
|
June 25, 2003
Losartan and E3174 pharmacokinetics in cytochrome P450 2C9*1/*1, *1/*2, and *1/*3 individuals
Craig R Lee, John A Pieper, Alan L Hinderliter, et al.
Clinical Chemistry
|
October 1, 1987
Liquid chromatography and fluorescence polarization immunoassay methods compared for measuring flecainide acetate in serum
R J Straka, T J Hoon, R L Lalonde, et al.
Clinical Pharmacology and Therapeutics
|
November 12, 2002
Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C91 heterozygotes
Craig R Lee, John A Pieper, Alan L Hinderliter, et al.
Journal of Clinical Pharmacology
|
March 1, 1995
Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome
S J Phelps, B S Alpert, J L Ward, et al.
Clinical Pharmacology and Therapeutics
|
April 29, 1998
Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers
K M Williamson, J H Patterson, R H McQueen, et al.
Scientific Reports
|
September 28, 2018
Neprilysin inhibition promotes corneal wound healing
Rachel M Genova, Kacie J Meyer, Michael G Anderson, et al.
American Journal of Hospital Pharmacy
|
June 1, 1983
Stability of cimetidine hydrochloride in admixtures after microwave thawing
G T Elliott, M W McKenzie, S H Curry, et al.
Annals of Medicine
|
September 30, 2006
The NPAS3 gene--emerging evidence for a role in psychiatric illness
Benjamin S Pickard, Andrew A Pieper, David J Porteous, et al.
Journal of Cardiovascular Pharmacology
|
May 1, 1991
Electrophysiologic effects of verapamil metabolites in the isolated heart
K E Johnson, S M Balderston, J A Pieper, et al.
Journal of Personality Assessment
|
December 1, 1995
Validation of the Clance Imposter Phenomenon Scale
S M Chrisman, W A Pieper, P R Clance, et al.
Page
of 28
Search research articles
Search
Showing results (111-120 of 278) with videos related to
Sort By:
Page
of 28
Pharmacotherapy
|
June 25, 2003
Losartan and E3174 pharmacokinetics in cytochrome P450 2C9*1/*1, *1/*2, and *1/*3 individuals
Craig R Lee, John A Pieper, Alan L Hinderliter, et al.
Clinical Chemistry
|
October 1, 1987
Liquid chromatography and fluorescence polarization immunoassay methods compared for measuring flecainide acetate in serum
R J Straka, T J Hoon, R L Lalonde, et al.
Clinical Pharmacology and Therapeutics
|
November 12, 2002
Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C91 heterozygotes
Craig R Lee, John A Pieper, Alan L Hinderliter, et al.
Journal of Clinical Pharmacology
|
March 1, 1995
Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome
S J Phelps, B S Alpert, J L Ward, et al.
Clinical Pharmacology and Therapeutics
|
April 29, 1998
Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers
K M Williamson, J H Patterson, R H McQueen, et al.
Scientific Reports
|
September 28, 2018
Neprilysin inhibition promotes corneal wound healing
Rachel M Genova, Kacie J Meyer, Michael G Anderson, et al.
American Journal of Hospital Pharmacy
|
June 1, 1983
Stability of cimetidine hydrochloride in admixtures after microwave thawing
G T Elliott, M W McKenzie, S H Curry, et al.
Annals of Medicine
|
September 30, 2006
The NPAS3 gene--emerging evidence for a role in psychiatric illness
Benjamin S Pickard, Andrew A Pieper, David J Porteous, et al.
Journal of Cardiovascular Pharmacology
|
May 1, 1991
Electrophysiologic effects of verapamil metabolites in the isolated heart
K E Johnson, S M Balderston, J A Pieper, et al.
Journal of Personality Assessment
|
December 1, 1995
Validation of the Clance Imposter Phenomenon Scale
S M Chrisman, W A Pieper, P R Clance, et al.
Page
of 28